SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-19-007713
Filing Date
2019-04-26
Accepted
2019-04-26 16:26:35
Documents
6
Period of Report
2019-06-13
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10001223x1_def14a.htm DEF 14A 2091068
2 nc10001223x1_piechart1.jpg GRAPHIC 127847
3 nc10001223x1_proxycards1.jpg GRAPHIC 1062080
4 nc10001223x1_proxycards2.jpg GRAPHIC 624164
5 sig_pgraham.jpg GRAPHIC 10701
6 sig_rapple.jpg GRAPHIC 9055
  Complete submission text file 0001140361-19-007713.txt   4494696
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 19772098
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10